1	agreement to undergo no change in concomitant medication include dietary supplement or therapeutic intervention during the first 12 week of the study that be the 12 week of dose with study drug except where medically indicate stable concomitant drug regimen great than two week pre-enrollment without|dietary supplement[65,83]|||||||12 week[129,136]|||71486|71486|dietary supplement
